After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced two poster ...

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

Elephas Biosciences Corporation (Elephas), a private company that has developed the elive™ ex vivo tumor profiling platform, ...

Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to ...

Neoadjuvant or perioperative immunotherapy, either alone or in combination with other antineoplastic agents (e.g., chemotherapy), has been shown to improve ...

Dr. Brittany Dulmage discusses how management of immune-related side effects can help patients stay on immunotherapy without compromising its effectiveness. As immunotherapy continues to transform ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

New targeted therapies reshape biliary tract cancer care, highlighting FGFR2/IDH1, HER2 and KRAS options plus smarter ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...

New biologics, precision diagnostics, and AI are reshaping care for rare allergies — from eosinophilic esophagitis to drug ...